1
TÍTULO: Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial
AUTORES: Michael G Hanna; Umesh A Badrising; Olivier Benveniste; Thomas E Lloyd; Merrilee Needham; Hector Chinoy; Masashi Aoki; Pedro M Machado; Christina Liang; Katrina A Reardon; Marianne de Visser; Dana P Ascherman; Richard J Barohn; Mazen M Dimachkie; James A L Miller; John T Kissel; Björn Oskarsson; Nanette C Joyce; Van den Bergh P.; Jonathan Baets; De Bleecker J.L.; Chafic Karam; William S David; Massimiliano Mirabella; Sharon P Nations; Hans H Jung; Pegoraro E.; Lorenzo Maggi; Carmelo Rodolico; Massimiliano Filosto; Aziz I Shaibani; Kumaraswamy Sivakumar; Namita A Goyal; Madoka Mori Yoshimura; Satoshi Yamashita; Suzuki N.; Masahisa Katsuno; Murata K.; Hiroyuki Nodera; Ichizo Nishino; Carla D Romano; Valerie S L Williams; John Vissing; Lixin Zhang Auberson; Min Wu; Ana de Vera; Dimitris A Papanicolaou; Anthony A Amato; ...Mais
PUBLICAÇÃO: 2019, FONTE: The Lancet Neurology, VOLUME: 18, NÚMERO: 9
INDEXADO EM: Scopus CrossRef: 76